DO34 analog
DO34 analog is a triazole DAGL (α) inhibitor extracted from patent WO2017096315 A1, compound 100.
Product Specifications
CAS Number
2098969-71-0
Product Name Alternative
PK-8165
UNSPSC
12352005
Target
DAGL
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/DO34_analog.html
Purity
98.42
Solubility
DMSO : ≥ 105 mg/mL
Smiles
O=C(N1C(CC2=CC=CC=C2)CN(C(OC(C)(C)C)=O)CC1)N3N=CC(C4=CC=C(OC(F)(F)F)C=C4)=N3
Molecular Formula
C26H28F3N5O4
Molecular Weight
531.53
References & Citations
[1]WO 2017096315 A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY433943 100 µg
Small leucine rich protein 1 (SmLR1) (NM_001195597) Human Over-expression Lysate
Sign In for Pricing
View Details 